XML 43 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Quarterly Data (Unaudited)
 12 Months Ended
Dec. 31, 2022
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Data (Unaudited) Quarterly Data (Unaudited):
The Spin Off of Enhabit was completed during 2022 and the historical results of Enhabit are now reported as discontinued operations. The quarterly results presented below have been reclassified to conform to this presentation. For additional information, see Note 2, Spin Off of Home Health and Hospice Business.
 2022
 FirstSecondThirdFourthTotal
 (In Millions, Except Per Share Data)
Net operating revenues$1,059.3 $1,062.5 $1,089.5 $1,137.3 $4,348.6 
Operating earnings (a)
131.5 128.6 127.5 151.9 539.5 
Provision for income tax expense 23.6 22.8 21.8 31.9 100.1 
Income from continuing operations86.4 59.8 85.5 119.0 350.7 
Income (loss) from discontinued operations, net of tax23.7 11.5 (18.5)(1.5)15.2 
Net income110.1 71.3 67.0 117.5 365.9 
Less: Net income attributable to noncontrolling interests(22.6)(22.6)(21.6)(28.1)(94.9)
Net income attributable to Encompass Health$87.5 $48.7 $45.4 $89.4 $271.0 
Earnings per common share:
Basic earnings per share attributable to Encompass Health common shareholders: (b)
Continuing operations
$0.65 $0.38 $0.64 $0.91 $2.58 
Discontinued operations
0.23 0.11 (0.19)(0.02)0.14 
Net income
$0.88 $0.49 $0.45 $0.89 $2.72 
Diluted earnings per share attributable to Encompass Health common shareholders: (b)
Continuing operations
$0.64 $0.38 $0.63 $0.90 $2.56 
Discontinued operations
0.23 0.11 (0.18)(0.01)0.14 
Net income
$0.87 $0.49 $0.45 $0.89 $2.70 
(a)We define operating earnings as income from continuing operations attributable to Encompass Health before (1) loss on early extinguishment of debt; (2) interest expense and amortization of debt discounts and fees; (3) other income; and (4) income tax expense.
(b)     Per share amounts may not sum due to the weighted average common shares outstanding during each quarter compared to the weighted average common shares outstanding during the entire year.
 2021
 FirstSecondThirdFourthTotal
 (In Millions, Except Per Share Data)
Net operating revenues$959.9 $1,001.7 $1,010.8 $1,042.5 $4,014.9 
Operating earnings (a)
143.0 146.8 141.4 128.4 559.6 
Provision for income tax expense25.0 28.2 26.2 22.5 101.9 
Income from continuing operations101.8 107.0 102.1 92.2 403.1 
Income from discontinued operations, net of tax31.0 35.0 24.6 23.5 114.1 
Net income132.8 142.0 126.7 115.7 517.2 
Less: Net income attributable to noncontrolling interests(25.5)(28.7)(26.7)(24.1)(105.0)
Net income attributable to Encompass Health$107.3 $113.3 $100.0 $91.6 $412.2 
Earnings per common share:
Basic earnings per share attributable to Encompass Health common shareholders: (b)
Continuing operations
$0.77 $0.79 $0.76 $0.69 $3.02 
Discontinued operations
0.31 0.35 0.24 0.23 1.13 
Net income
$1.08 $1.14 $1.00 $0.92 $4.15 
Diluted earnings per share attributable to Encompass Health common shareholders: (b)
Continuing operations
$0.76 $0.79 $0.76 $0.68 $2.99 
Discontinued operations
0.31 0.34 0.24 0.23 1.12 
Net income
$1.07 $1.13 $1.00 $0.91 $4.11 
(a)We define operating earnings as income from continuing operations attributable to Encompass Health before (1) loss on early extinguishment of debt; (2) interest expense and amortization of debt discounts and fees; (3) other income; and (4) income tax expense.
(b)     Per share amounts may not sum due to the weighted average common shares outstanding during each quarter compared to the weighted average common shares outstanding during the entire year.